Business Context and Reporting Period
This Form 8-K Current Report was filed by Marchex, Inc. on October 7, 2020, regarding events occurring on October 7 and October 8, 2020. The company is incorporated in Delaware and its Class B Common Stock trades on The Nasdaq Global Select Market under the symbol MCHX.
Key Financial Metrics
This filing does not contain standard financial performance metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The report focuses exclusively on a specific corporate action involving a tender offer.
Material Changes and Events
On October 8, 2020, Marchex, Inc. announced the results of a joint and equal tender offer conducted with Edenbrook Capital, LLC. Key details include:
- Offer Terms: Up to 10 million shares of Class B common stock were sought at a price of $2.15 per share.
- Conditions: The offer was conditioned on a minimum of 3 million shares being properly tendered.
- Expiration: The offer expired at 11:59 p.m. New York City time on October 7, 2020.
- Results: A total of 10,552,160 shares were properly tendered and not withdrawn, exceeding the maximum offer size of 10 million shares.
- Guaranteed Delivery: Approximately 86,461 of the tendered shares were submitted through notices of guaranteed delivery.
Guidance, Outlook, and Risks
The filing does not provide updated financial guidance, management commentary on future outlook, or specific risk factors beyond the execution of the tender offer. The primary contingency noted was the minimum tender condition, which was successfully met.
Investor Verification Checklist
- Verify the final settlement price and pro-rata allocation details for the excess shares tendered (10,552,160 tendered vs. 10,000,000 maximum).
- Confirm the total cash consideration paid to shareholders upon settlement of the offer.
- Review the updated share count and capitalization table following the repurchase.
- Check for any subsequent filings regarding the impact of this transaction on the company's liquidity or debt covenants.